MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
What is AML?

Acute Myelogenous Leukemia (AML) is a clonal hematopoietic stem cell cancer within the myeloid continuum of diseases. Like other myeloid diseases, AML originates in the factory cells of the bone marrow. There are different types of AML, each with variable time to onset, prognosis, and treatment options: De-novo AML; Secondary AML (sAML); Treatment related AML (tAML); and AML with Myelodysplastic Changes (AML-MRC)

An Animated Patient’s Guide to AML

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This resource is intended for patients with acute myeloid leukemia (AML). You will find expert advice about AML to help you discuss key issues with your healthcare provider and make important decisions related to management and treatment. Easy-to-understand animations with audio narration, expert video explanations, illustrated slide shows, and educational downloads are available to you.

Learn More



Thank you to Jazz Pharmaceuticals for supporting this resource.

Complete the following form to request a printed copy of the Building Blocks of Hope

Review answers to commonly asked questions or get answers to your questions from an MDS expert